Avertis Group is an independent capital advisory firm working with ambitious FinTech, MedTech, Healthcare and AI companies from Series A onwards.
We partner with founders, CEOs, CFOs and management teams during critical stages of growth — helping them prepare for institutional capital, position their investment case and execute financing and strategic transactions.
Avertis Group was built around a simple principle: companies approaching transformational financing or strategic decisions need more than investor introductions.
They need a partner capable of understanding the business, translating its potential into an institutional investment proposition and running a disciplined capital process alongside management.
We operate as an extension of the management team — combining capital strategy, investor readiness, investor targeting and transaction execution within one advisory relationship.
We deliberately maintain a focused mandate portfolio to provide direct senior involvement throughout every engagement.
A strong company does not automatically create a strong investment case.
Institutional investors evaluate businesses through a different lens: market opportunity, defensibility, management, scalability, financial performance, risk, valuation and potential returns.
Our role is to bridge that gap. We help management teams articulate why their company represents a compelling investment opportunity and bring that proposition to the investors most capable of supporting its next stage.
The company must be understood before it can be positioned. Positioning is what investors actually evaluate.
We primarily advise venture-backed and growth-stage companies that meet most of the following conditions.
Companies with meaningful commercial, technological or clinical validation.
Typically institutional financing, growth capital or a strategic transaction.
FinTech, MedTech, Healthcare and Artificial Intelligence.
Companies building businesses capable of attracting sophisticated global capital.
Management teams seeking a capital advisory partner rather than an investor database.
Five commitments that govern every mandate we accept.
We only accept mandates where we believe there is genuine investor relevance and a credible path to execution.
Our engagement structures are designed to align Avertis with the long-term objectives of management and shareholders.
We prioritise investor fit over mass outreach.
Mandates receive direct strategic attention throughout the engagement.
Capital and transaction processes are handled discreetly and professionally.
Whether you are preparing a Series A, executing a growth round or considering a strategic transaction, we can assess where Avertis may add value.